Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 1
1962 1
1965 1
1966 1
1967 1
1970 1
1972 3
1973 1
1974 1
1975 1
1984 1
1986 1
1988 5
1989 2
1990 3
1991 4
1992 5
1993 1
1994 5
1995 7
1996 6
1997 7
1999 7
2000 9
2001 7
2002 6
2003 1
2004 3
2005 1
2006 1
2007 1
2009 5
2010 1
2011 1
2012 1
2013 1
2014 1
2015 1
2016 5
2017 6
2018 5
2019 5
2021 8
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

132 results
Results by year
Filters applied: . Clear all
Page 1
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer.
Chrysostomou S, Roy R, Prischi F, Thamlikitkul L, Chapman KL, Mufti U, Peach R, Ding L, Hancock D, Moore C, Molina-Arcas M, Mauri F, Pinato DJ, Abrahams JM, Ottaviani S, Castellano L, Giamas G, Pascoe J, Moonamale D, Pirrie S, Gaunt C, Billingham L, Steven NM, Cullen M, Hrouda D, Winkler M, Post J, Cohen P, Salpeter SJ, Bar V, Zundelevich A, Golan S, Leibovici D, Lara R, Klug DR, Yaliraki SN, Barahona M, Wang Y, Downward J, Skehel JM, Ali MMU, Seckl MJ, Pardo OE. Chrysostomou S, et al. Among authors: peach r. Sci Transl Med. 2021 Jul 14;13(602):eaba4627. doi: 10.1126/scitranslmed.aba4627. Sci Transl Med. 2021. PMID: 34261798 Free PMC article.
RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis.
Hirano I, Collins MH, Assouline-Dayan Y, Evans L, Gupta S, Schoepfer AM, Straumann A, Safroneeva E, Grimm M, Smith H, Tompkins CA, Woo A, Peach R, Frohna P, Gujrathi S, Penenberg DN, Li C, Opiteck GJ, Olson A, Aranda R, Rothenberg ME, Dellon ES; HEROES Study Group. Hirano I, et al. Among authors: peach r. Gastroenterology. 2019 Feb;156(3):592-603.e10. doi: 10.1053/j.gastro.2018.10.051. Epub 2018 Nov 2. Gastroenterology. 2019. PMID: 30395812 Free article. Clinical Trial.
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity.
Scott FL, Clemons B, Brooks J, Brahmachary E, Powell R, Dedman H, Desale HG, Timony GA, Martinborough E, Rosen H, Roberts E, Boehm MF, Peach RJ. Scott FL, et al. Among authors: peach rj. Br J Pharmacol. 2016 Jun;173(11):1778-92. doi: 10.1111/bph.13476. Epub 2016 Apr 28. Br J Pharmacol. 2016. PMID: 26990079 Free PMC article.
HCGA: Highly comparative graph analysis for network phenotyping.
Peach RL, Arnaudon A, Schmidt JA, Palasciano HA, Bernier NR, Jelfs KE, Yaliraki SN, Barahona M. Peach RL, et al. Patterns (N Y). 2021 Apr 2;2(4):100227. doi: 10.1016/j.patter.2021.100227. eCollection 2021 Apr 9. Patterns (N Y). 2021. PMID: 33982022 Free PMC article.
Structural biology of the S1P1 receptor.
Hanson MA, Peach R. Hanson MA, et al. Among authors: peach r. Curr Top Microbiol Immunol. 2014;378:23-53. doi: 10.1007/978-3-319-05879-5_2. Curr Top Microbiol Immunol. 2014. PMID: 24728592 Review.
Anion-Exchange Membrane Water Electrolyzers.
Du N, Roy C, Peach R, Turnbull M, Thiele S, Bock C. Du N, et al. Among authors: peach r. Chem Rev. 2022 Apr 20. doi: 10.1021/acs.chemrev.1c00854. Online ahead of print. Chem Rev. 2022. PMID: 35442645 Review.
132 results